Investors Press Releases Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT” December 20, 2018 Cardiol Therapeutics Appoints Mr. Chris Waddick as Chief Financial Officer, Ms. Anne Tomalin as Director of Regulatory Affairs, and Ms. Dolly Kao as Intellectual Property Counsel August 30, 2018 Cardiol Therapeutics Appoints Dr. Eldon Smith as Chairman and Dr. Guillermo Torre-Amione, Ms. Deborah Brown, and Mr. Iain Chalmers to its Board of Directors August 21, 2018 Cardiol Therapeutics Closes $10.5 Million Private Placement May 24, 2018 Cardiol Therapeutics Appoints Dr. James Young as Chair of the Company’s Scientific Advisory Board May 08, 2018 Cardiol Therapeutics to Present at the 2018 BIO CEO & Investor Conference in NYC February 06, 2018 Cardiol Therapeutics Demonstrates Novel Way to Target Drugs for Treating Heart Failure Using Nanotechnology January 09, 2018 Cardiol Therapeutics to Present at the 2018 Biotech Showcase in San Francisco January 03, 2018 Cardiol Therapeutics Appoints Bruce Hirsche and Peter Pekos to Board of Directors December 15, 2017 Cardiol Signs Letter of Intent with TecSalud and Nano4heart for the Development of Heart Failure Therapies November 17, 2017 Page 2 of 3«123»
